BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 32883070)

  • 1. Precisely Assembled Nanoparticles against Cisplatin Resistance via Cancer-Specific Targeting of Mitochondria and Imaging-Guided Chemo-Photothermal Therapy.
    Yang GG; Pan ZY; Zhang DY; Cao Q; Ji LN; Mao ZW
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43444-43455. PubMed ID: 32883070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
    Tan MX; Wang ZF; Qin QP; Zou BQ; Liang H
    Dalton Trans; 2020 Feb; 49(5):1613-1619. PubMed ID: 31942585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multipronged Design of Light-Triggered Nanoparticles To Overcome Cisplatin Resistance for Efficient Ablation of Resistant Tumor.
    Li Y; Deng Y; Tian X; Ke H; Guo M; Zhu A; Yang T; Guo Z; Ge Z; Yang X; Chen H
    ACS Nano; 2015 Oct; 9(10):9626-37. PubMed ID: 26365698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving traceless ablation of solid tumors without recurrence by mild photothermal-chemotherapy of triple stimuli-responsive polymer-drug conjugate nanoparticles.
    Du C; Ding Y; Qian J; Zhang R; Dong CM
    J Mater Chem B; 2019 Jan; 7(3):415-432. PubMed ID: 32254729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
    He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y
    Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imidazole modified Pt(iv) prodrug-loaded multi-stage pH responsive nanoparticles to overcome cisplatin resistance.
    Kang X; Wang Y; Chen Z; Wu Y; Chen H; Yang X; Yu C
    Chem Commun (Camb); 2020 Sep; 56(76):11271-11274. PubMed ID: 32830841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer.
    Pathak RK; Wen R; Kolishetti N; Dhar S
    Mol Cancer Ther; 2017 Apr; 16(4):625-636. PubMed ID: 28148716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conveniently synthesized Pt (IV) conjugated alginate nanoparticle with ligand self-shielded property for targeting treatment of hepatic carcinoma.
    Wang X; Chang Z; Nie X; Li Y; Hu Z; Ma J; Wang W; Song T; Zhou P; Wang H; Yuan Z
    Nanomedicine; 2019 Jan; 15(1):153-163. PubMed ID: 30308299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.
    Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G
    Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance.
    Wang Z; Xu Z; Zhu G
    Angew Chem Int Ed Engl; 2016 Dec; 55(50):15564-15568. PubMed ID: 27736029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
    Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
    J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-Stimuli-Responsive Multifunctional Gd
    Kuang Y; Zhang Y; Zhao Y; Cao Y; Zhang Y; Chong Y; Pei R
    ACS Appl Mater Interfaces; 2020 Aug; 12(32):35928-35939. PubMed ID: 32686939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming tumor resistance to cisplatin by cationic lipid-assisted prodrug nanoparticles.
    Cao ZT; Chen ZY; Sun CY; Li HJ; Wang HX; Cheng QQ; Zuo ZQ; Wang JL; Liu YZ; Wang YC; Wang J
    Biomaterials; 2016 Jul; 94():9-19. PubMed ID: 27088406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood.
    Datta P; Bang S; Yue Z; Beach T; Stilgenbauer M; Wang H; Bowers DJ; Kurokawa M; Xiao H; Zheng YR
    Dalton Trans; 2020 Jun; 49(24):8107-8113. PubMed ID: 32490446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergic highly effective photothermal-chemotherapy with platinum prodrug linked melanin-like nanoparticles.
    Zhang C; Zhao X; Guo H
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):356-363. PubMed ID: 29607699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocoumarinplatin, targeting simultaneously mitochondria and nuclei with p53 apoptosis pathway to overcome cisplatin resistance.
    Ma J; Li L; Yue K; Li Y; Liu H; Wang PG; Wang C; Wang J; Luo W; Xie S
    Bioorg Chem; 2020 Jun; 99():103768. PubMed ID: 32217375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles.
    Wu R; Zhang Z; Wang B; Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
    Drug Des Devel Ther; 2020; 14():2249-2261. PubMed ID: 32606595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembled Lipid Nanoparticles for Ratiometric Codelivery of Cisplatin and siRNA Targeting XPF to Combat Drug Resistance in Lung Cancer.
    Li C; Li T; Huang L; Yang M; Zhu G
    Chem Asian J; 2019 May; 14(9):1570-1576. PubMed ID: 30843348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel NF-κB Inhibitor-Conjugated Pt(IV) Prodrug to Enable Cancer Therapy through ROS/ER Stress and Mitochondrial Dysfunction and Overcome Multidrug Resistance.
    Wang M; Li G; Jiang G; Cai J; Liu Z; Huang R; Huang X; Wang H
    J Med Chem; 2024 Apr; 67(8):6218-6237. PubMed ID: 38573870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo.
    Yu C; Ding B; Zhang X; Deng X; Deng K; Cheng Z; Xing B; Jin D; Ma P; Lin J
    Biomaterials; 2018 Feb; 155():112-123. PubMed ID: 29175080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.